Figure 1From: Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS studyStudy design. aIn patients who had not reached the European goal of LDL-C<3.0 mmol/L after 4 weeks, the statin dose was doubled at each visit, up to a maximum of RSV 40 mg and ATV 80 mg RSV: Rosuvastatin, ATV: Atorvastatin, LDL-C: Low-density lipoprotein cholesterolBack to article page